The Effect of SP/NK1R on the Expression and Activity of Catalase and Superoxide Dismutase in Glioblastoma Cancer Cells.

Faranak Korfi Dr Hossein Javid Reza Assaran Darban Seyed Isaac Hashemy

Published in: Biochemistry research international (2021)

The present study showed that aprepitant inhibited SP's oxidizing effects via inducing the antioxidant effects of catalase and SOD in the U87 cell line. Therefore, this drug might be introduced as a potential candidate for controlling glioblastoma cancer in animal models and clinical trials.

Keyphrases

clinical trial
poor prognosis
oxidative stress
emergency department
squamous cell carcinoma
anti inflammatory
binding protein
long non coding rna
randomized controlled trial
climate change
open label
young adults
phase iii